Mike PolandMar 29, 2022Maximizing Specialty Pharmacy ContractsWhen approached strategically, contracting with SP networks can positively impact patient experience and the company’s bottom line.
Grace BerginMar 14, 2022What the CMS Final Rule on Copay Programs Means for Pharmaceutical ManufacturersIt is vital for pharmaceutical manufacturers to consider how much financial and reputational risk they may face as a result of the pending C
Melissa AylesFeb 27, 2022Rare Disease Resources Every Pharma and Biotech Company Should KnowWe often advise our clients that there are many varied ways to better understand and engage with rare disease patients.